APA (7th ed.) Citation

S, L., X, Y., H, C., Z, C., & Y, Y. (2023). Clinical efficacy of prostate PI-RADS V2.1 score combined with serum PSA-related indicators in the detection of gray zone prostate cancer. International urology and nephrology, 55(11), 2685. https://doi.org/10.1007/s11255-023-03692-0

Chicago Style (17th ed.) Citation

S, Lin, Yu X, Chen H, Chen Z, and Yang Y. "Clinical Efficacy of Prostate PI-RADS V2.1 Score Combined with Serum PSA-related Indicators in the Detection of Gray Zone Prostate Cancer." International Urology and Nephrology 55, no. 11 (2023): 2685. https://doi.org/10.1007/s11255-023-03692-0.

MLA (9th ed.) Citation

S, Lin, et al. "Clinical Efficacy of Prostate PI-RADS V2.1 Score Combined with Serum PSA-related Indicators in the Detection of Gray Zone Prostate Cancer." International Urology and Nephrology, vol. 55, no. 11, 2023, p. 2685, https://doi.org/10.1007/s11255-023-03692-0.